NCT02139436

Brief Summary

Each year, 11,000 people suffer a spinal cord injury (SCI) in the U.S. Within the first year, there are profound declines in physiologic function, forming the underlying substrate for future cardiovascular disease . In fact, acquired cardiovascular disease is an increasingly recognized consequence of SCI and is the leading cause of death in SCI. Though incompletely understood, the almost 10-fold prevalence of cardiovascular disease results in part from profound physiologic 'detraining' resulting from motor impairment and immobility. Currently, effective interventions preventing acute declines that lead to cardiovascular compromise and increased risk in SCI are lacking - exercise therapy for those with SCI is challenging and when employed, is typically limited to the upper body. Recently, the investigators refined a unique form of exercise for those with SCI that specifically mirrors exercise performed by those without SCI. Functional Electrical Stimulation (FES) Row Training (RT) couples volitional arm and electrically controlled leg exercise, resulting in a hemodynamic profile that produces the beneficial cardiac loading conditions of large muscle mass exercise. As such, FES-RT may be a safe and effective way to attenuate cardiovascular declines following SCI. The investigators aims are to test the overall hypotheses that FES-RT will: 1) mitigate against increased visceral adiposity and reduced insulin sensitivity, 2) prevent worsening lipid profile and compromised baroreflex function, and 3) counter ventricular wall thickening and declining ventricular function occurring with acute SCI, and that these effects will be greater than that observed with an arms-only exercise group. Changes with FES-RT will be compared to a time (wait-list) control and to arms-only-RT. Individuals with an SCI within the last 3-6 months will be randomized to FES-RT, to a time control, or arms-only-RT. Measures will be made at baseline and 6 months. The investigators work will provide results that clearly delineate potential health benefits of FES-RT, and if FES-RT is effective in a majority of those with SCI, its application, implementation, and integration could be easily replicated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 12, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 15, 2014

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

March 22, 2022

Completed
Last Updated

March 22, 2022

Status Verified

February 1, 2022

Enrollment Period

6.3 years

First QC Date

May 12, 2014

Results QC Date

January 5, 2022

Last Update Submit

February 28, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • Change From Baseline in Exercise Capacity at 6 Months

    Volunteers will perform an incremental exercise test of FES- or arms-only rowing to determine maximal oxygen uptake.

    Baseline and 6 months

  • Change From Baseline in Visceral Adiposity at 6 Months

    We will use a 5th generation General Electric Healthcare dual x-ray absorptiometry(DXA) scanner for regional fat measurements, the DXA software can be used to define standard regions that will allow comparability of measurements throughout the study.

    Baseline, 6 months

  • Change From Baseline in Myocardial Structure at 6 Months.

    Echocardiography was performed using a commercially available system(Vivid-1, General Electric Healthcare)to obtain measures of left ventricular wall thickness and left ventricular diastolic function.

    Baseline and 6 months

  • Change From Baseline in Insulin Sensitivity at 6 Months.

    Blood will be taken via standard venipuncture to measure the homeostasis model assessment of insulin resistance (HOMA-IR). HOMA-IR is a measure of insulin resistance/sensitivity calculated by multiplying fasting insulin (μU/mL) by fasting glucose (mg/dL) and divided by a constant (405). A higher value indicates higher insulin resistance.

    Baseline and 6 months

  • Change From Baseline in Blood Lipids at 6 Months

    Blood will be taken via standard venipuncture to measure: total cholesterol.

    Baseline and 6 months

Study Arms (3)

FES-row-training

EXPERIMENTAL

Subjects will perform 6 months of FES-row-training.

Other: FES-row-training

Wait-list time control

OTHER

Subjects perform 6 months of their standard of care

Other: Time Control

Arms-only-row-training

ACTIVE COMPARATOR

Subjects will perform 6 months of arms-only row training

Other: Arms-only-row training

Interventions

FES-row-training
Arms-only-row-training
Wait-list time control

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Spinal cord injured outpatients aged 18-40
  • medically stable
  • body mass index 18.5-30.0
  • months post SCI
  • ASIA scale A, B or C at neurological level C5-T12
  • able to follow directions
  • leg muscles responsive to FES

You may not qualify if:

  • hypertension
  • significant arrhythmias
  • coronary artery disease
  • diabetes
  • renal disease
  • cancer
  • epilepsy
  • current use of cardioactive medications
  • current grade 2 or greater pressure ulcers at relevant contact sites
  • other neurological disease
  • peripheral nerve compressions or rotator cuff tears that limit ability to row
  • history of bleeding disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Spaulding Hospital Cambridge

Cambridge, Massachusetts, 02138, United States

Location

Related Publications (5)

  • Yates BA, Brown R, Picard G, Taylor JA. Improved pulmonary function is associated with reduced inflammation after hybrid whole-body exercise training in persons with spinal cord injury. Exp Physiol. 2023 Mar;108(3):353-360. doi: 10.1113/EP090785. Epub 2023 Jan 9.

  • Ely MR, Schleifer GD, Singh TK, Baggish AL, Taylor JA. Exercise Training Does Not Attenuate Cardiac Atrophy or Loss of Function in Individuals With Acute Spinal Cord Injury: A Pilot Study. Arch Phys Med Rehabil. 2023 Jun;104(6):909-917. doi: 10.1016/j.apmr.2022.12.001. Epub 2022 Dec 23.

  • Solinsky R, Schleifer GD, Draghici AE, Hamner JW, Taylor JA. Methodologic implications for rehabilitation research: Differences in heart rate variability introduced by respiration. PM R. 2022 Dec;14(12):1483-1489. doi: 10.1002/pmrj.12770. Epub 2022 Mar 12.

  • Solinsky R, Draghici A, Hamner JW, Goldstein R, Taylor JA. High-intensity, whole-body exercise improves blood pressure control in individuals with spinal cord injury: A prospective randomized controlled trial. PLoS One. 2021 Mar 4;16(3):e0247576. doi: 10.1371/journal.pone.0247576. eCollection 2021.

  • Ely MR, Singh TK, Baggish AL, Taylor JA. Reductions in Cardiac Structure and Function 24 Months After Spinal Cord Injury: A Cross-Sectional Study. Arch Phys Med Rehabil. 2021 Aug;102(8):1490-1498. doi: 10.1016/j.apmr.2021.01.070. Epub 2021 Feb 5.

MeSH Terms

Conditions

Spinal Cord Injuries

Interventions

Flowering time control protein FCA, Arabidopsis

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Results Point of Contact

Title
Glen Picard
Organization
Spaulding Rehabilitation Hospital

Study Officials

  • J. Andrew Taylor, Ph.D.

    Spaulding Rehabilitation Hospital/Harvard Medical School

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Three intervention groups (Control, AO-Row, and FES-RT) run in parallel
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Cardiovascular Research Laboratory

Study Record Dates

First Submitted

May 12, 2014

First Posted

May 15, 2014

Study Start

December 1, 2013

Primary Completion

March 1, 2020

Study Completion

March 1, 2021

Last Updated

March 22, 2022

Results First Posted

March 22, 2022

Record last verified: 2022-02

Locations